![](/img/cover-not-exists.png)
The POWER-tool: Recommendations for involving patient representatives in choosing relevant outcome measures during rare disease clinical trial design
Gaasterland, C.M.W., Jansen-van der Weide, M.C., Vroom, E., Leeson-Beevers, K., Kaatee, M., Kaczmarek, R., Bartels, B., van der Pol, W.L., Roes, K.C.B., van der Lee, J.H.Language:
english
Journal:
Health Policy
DOI:
10.1016/j.healthpol.2018.09.011
Date:
September, 2018
File:
PDF, 766 KB
english, 2018